News
Treatments designed to help patients preserve muscle while losing weight with popular obesity drugs by Eli Lilly and Novo ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) is among the best NASDAQ stocks under $50 to buy. On Monday, analysts at TD Cowen ...
In a report released yesterday, Bryan Bergin from TD Cowen maintained a Buy rating on Accenture (ACN – Research Report), with a price target of $342.00. The company’s shares c ...
Despite competitive pressures in the AI space, “the rising tide” in AI technology adoption is set to benefit multiple ...
Detailed price information for Copa Holdings S.A. (CPA-N) from The Globe and Mail including charting and trades.
TD Cowen has added Gap Inc (NYSE: GAP) to its “Best Smidcap Ideas” list, citing sustained momentum at its core Gap and Old ...
Investing.com-- TD Cowen downgraded its rating on Sarepta Therapeutics Inc (NASDAQ: SRPT) and slashed its price target ...
The unmet need to preserve muscle will grow with the use of GLP-1 drugs for obesity, said TD Cowen analyst Tyler Van Buren. Doctors have raised concerns that patients may experience a decrease in ...
Privia Health Group, Inc. (NASDAQ:PRVA) is among the best NASDAQ stocks under $50 to buy. Analysts at TD Cowen have named ...
1d
TipRanks on MSNSoleno Therapeutics initiated with a Buy at TD CowenTD Cowen analyst Tyler Van Buren initiated coverage of Soleno Therapeutics (SLNO) with a Buy rating and $110 price target The firm says Vykat XR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results